BioNTech, Fosun start COVID-19 vaccine trial to support Chinese approval

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 25, 2020 at 10:53 AM.

  1. #1 cafead, Nov 25, 2020 at 10:53 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via BioNTech and Fosun Pharma have begun a phase 2 trial of their COVID-19 vaccine in China. The trial will generate data to support a filing for approval of the vaccine, which is nearing authorization in the West, in China.

    article source
     
    Quote

Reply to Thread